Expanded Carrier Screening and the Complexity of Implementation.

@article{Silver2021ExpandedCS,
  title={Expanded Carrier Screening and the Complexity of Implementation.},
  author={Julia Silver and Mary E. Norton},
  journal={Obstetrics \& Gynecology},
  year={2021},
  url={https://api.semanticscholar.org/CorpusID:231195142}
}
Advances in genetic technology have allowed for the development of multiplex panels that can test for hundreds of genetic disorders at the same time; these large panels are referred to as expanded carrier screening. This process can screen couples for far more conditions than the gene-by-gene approach used with traditional carrier screening; however, although expanded carrier screening has been promoted as an efficient means of detecting many more disorders, the complexities of genetic… 

The Evolving Landscape of Genetic Carrier Screening: Clinical Considerations and Challenges

This review aims to provide an overview of the history of prenatal genetic screening and the various forms of carrier screening, a synopsis of recent changes in society recommendations and current practice guidelines, and discussion of clinical challenges associated with carrier screening.

Ethical considerations in gene selection for reproductive carrier screening

This paper considers three aspects of selecting genes for population reproductive genetic carrier screening panels that give rise to important ethical considerations: severity, variable penetrance and expressivity, and scalability; and draws on three exemplar genes to illustrate the ethical issues raised.

Expanded carrier screening in the United States: A systematic evidence review exploring client and provider experiences

Findings suggest that client and provider perceptions of ECS and minimal guideline‐based carrier screening are multifaceted, including the need to examine variant interpretation and use of next‐generation sequencing.

Considering severity in the design of reproductive genetic carrier screening programs: screening for severe conditions

It is suggested that screening programs should be oriented more towards variants and genes associated with severe conditions, and the importance of taking a practical approach to gene selection in a carrier screening program when presenting the offer at population scale is discussed.

Attitudes of professional stakeholders towards implementation of reproductive genetic carrier screening: a systematic review

One major stumbling block on how to responsibly inform couples about hundreds different genetic conditions within constraints regarding time and ability of non-genetic professionals is highlighted.

Experiences of nonpregnant couples after receiving reproductive genetic carrier screening results in Belgium

It is demonstrated that the information/counseling and reporting strategy that was used in the context of this study led to high participant satisfaction, an increase in knowledge over time and favorable psychosocial and counseling-related outcomes.

Incidence of Duchenne muscular dystrophy in the modern era; an Australian study

Investigating disease incidence within an Australian model of cascade screening and evolving genetic diagnostic technologies finds innovative approaches to reduce DMD incidence may be better achieved by preconception or early pregnancy carrier screening, prenatal exome sequencing and newborn screening.

A robust pipeline for ranking carrier frequencies of autosomal recessive and X-linked Mendelian disorders

A robust pipeline for estimating and ranking carrier frequencies of all known 2699 recessive genes based on genome-wide sequencing data in healthy individuals is established and high degree of correlation is exhibited between the ChinaMAP and the WBBC cohorts, confirming the validity of the variant selection criteria and the overall analysis pipeline.

Ethnically unique disease burden and limitations of current expanded carrier screening panels

The purpose of the study is to identify the recessive diseases currently affecting real‐world pediatric patients in Taiwan, and whether current extended carrier screening panels have the coverage and

Carrier Screening for Single-Gene Disorders

    L. Dugoff
    Medicine
  • 2021
To earn CME credit, you must read the CME article and complete the quiz and evaluation on the enclosed answer form, answering at least seven of the 10 quiz questions correctly.

The evolving landscape of expanded carrier screening: challenges and opportunities

Challenges for expanded carrier screening programs include a lack of demand from the public, low prioritization by health systems, the potential for pressure to undergo screening, the possibility of disability-based discrimination, needed adaptations to pre- and post-test counseling, technical limitations, and the evolving technological and socio-political landscape.

Responsible implementation of expanded carrier screening

The challenges that expanded carrier screening might pose in the context of the lessons learnt from decades of population-based carrier screening and in thecontext of existing screening criteria are discussed.

ACMG position statement on prenatal/preconception expanded carrier screening

The basis for the selection of disorders on expanded carrier screening panels should be disclosed and the information provided about disorders with mild phenotypes, variable expression, low penetrance, and/or characterized by an adult onset should be complete and transparent.

Finding Middle Ground in Constructing a Clinically Useful Expanded Carrier Screening Panel.

This commentary proposes specific criteria for the development of expanded carrier screening panels that will maximize clinical utility and minimize patient stress, unnecessary cost of follow-up testing, and clinician time spent facilitating and performing follow- up counseling and testing.

Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening.

To quantify the modeled risk of recessive conditions identifiable by an expanded carrier screening panel in individuals of diverse racial and ethnic backgrounds and to compare the results with those from current screening recommendations, retrospective modeling analysis of results between January 1, 2012, and July 15, 2015 is analyzed.

Committee Opinion No. 690: Carrier Screening in the Age of Genomic Medicine.

Carrier screening, whether targeted or expanded, allows individuals to consider their range of reproductive options. Ultimately, the goal of genetic screening is to provide individuals with

Committee Opinion No. 691: Carrier Screening for Genetic Conditions.

What follows is a detailed discussion of some of the more common genetic conditions for which carrier screening is recommended in at least some segments of the population.

Preconception carrier screening yield: effect of variants of unknown significance in partners of carriers with clinically significant variants

Findings underscore the importance of VUS reclassification in ECS, which will crucially depend on enlarging population frequency databases, especially of affected individuals.